Thrombin-Induced Platelet Malondialdehyde (MDA) Formation in Normal Subjects and in Women Taking Oral Contraceptives

Summary

Thrombin-induced platelet malondialdehyde (MDA) production and platelet count were studied in 82 male and 74 female healthy blood donors. 37 women on oral contraceptives (OC) had significantly lower values of MDA production than women who were not using the pill. There were no statistically significant differences of MDA production in women on a low dose estrogen, a medium dose, and a relatively high dose. Males had significantly higher values than females. In 15 further subjects (5 males, 5 OC-users, 5 OC-nonusers) the kinetics of MDA formation was determined by using increasing doses of thrombin. No significant differences could be found. Platelet count in women on OCs was lightly increased, but the difference was not significant.

Keywords

Platelet MDA production - Normal values - Oral contraceptives

• References

• 1 Meade TW, Haines AP, North WRS, Chakrabarti R, Howarth DJ, Stirling Y. Hemostatic, lipid and blood pressure profiles of women on oral contraceptives containing 50 ug or 30 ug oestrogen. Lancet 1977; 2: 948-951
• 2 Meade TW, Brozovic M, Chakrabarti R, Howarth DJ, North WRS, Stirling Y. An epidemiological study of the haemostatic and other effects of oral contraceptives. Br J Haematol 1976; 34: 353-364
• 3 Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Jones PK. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. J lab Clin Med 1980; 96: 762-769
• 4 Bierenbaum ML, Fleischman AI, Stier A, Watson P, Somol H, Naso AM, Binder M. Increased platelet aggregation and decreased high-density lipoprotein cholesterol in women on oral contraceptives. Am J Obstetr Gynecol 1979; 134: 638-641
• 5 McQueen E. Hormonal steroid contraceptives. Adverse reactions. Drugs 1971; 2: 20-27
• 6 Gerrard JM, White JG. Prostaglandins and thromboxanes: “middlemen” modulating platelet function in hemostasis and thrombosis. In: Progress in hemostasis and thrombosis. Spaet TH. (ed) Grune & Stratton; NY: 1978. 4 87-125
• 7 Sadurska B, Tacconi MT, Minno Gdi, Roncaglioni MC, Pangrazzi J, Donati MB, Bizzi A, Silver MJ. Plasma and platelet lipid composition and platelet aggregation by arachidonic acid in women on the pill. Thromb Hemostas 1981; 45: 150-153
• 8 Schorer AE, Gerrard JM, White JG, Krivit W. Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesis. Prostaglandins Med 1978; 1: 5-11
• 9 Tindall H, Zuzel M, Paton RC, McNicol GP. Changes in thrombin-stimulated platelet malondialdehyde production during the menstrual cycle. J Clin Pathol 1981; 34: 595-598
• 10 Voss Hv, Göbel V, Bergmann F. Methodical investigations for determination of malonyldialdehyde-production by platelet. Blut 1979; 38: 86
• 11 Fabris F, Casonato A, Randi M, Girolami A. In vitro and in vivo effects of Ditazol on human platelets malonylaldehyde (MDA) production. Folia Haematol 1981; 3: 433-438